DECR1 Antibodies

Santa Cruz Biotechnology provides a broad selection of DECR1 monoclonal antibodies for research focused on understanding DECR1 protein functions. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DECR1, or 2,4-dienoyl-CoA reductase 1, plays a crucial role in fatty acid metabolism, specifically in the breakdown of unsaturated fatty acids. DECR1 maintains cellular energy homeostasis and has significant implications in metabolic disorders. Research involving DECR1 can enhance understanding of various physiological processes. Investigating DECR1 functions may reveal potential therapeutic targets for metabolic conditions. DECR1 studies contribute to advancing knowledge in cellular metabolism and energy regulation. Exploring DECR1's role in fatty acid pathways provides valuable insights into metabolic health and disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of DECR1's role in human health and disease.